See the DrugPatentWatch profile for humira
What is Humira used to treat?
Humira (adalimumab) is a prescription medicine used for several inflammatory and autoimmune conditions. It is commonly used to treat diseases where the immune system causes chronic inflammation, including:
- Rheumatoid arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Crohn’s disease
- Ulcerative colitis
- Plaque psoriasis
- Juvenile idiopathic arthritis
- Hidradenitis suppurativa
- Uveitis
Why do doctors prescribe it?
Humira targets tumor necrosis factor (TNF), a protein involved in inflammation. By blocking TNF, it can reduce swelling, pain, and other symptoms and help control disease activity in conditions like arthritis and inflammatory bowel disease.
Can Humira be used for children?
Yes. Humira is used for certain pediatric inflammatory conditions, including juvenile idiopathic arthritis.
What should patients know before starting?
Humira suppresses part of the immune response, so patients are usually screened for infection risks before starting (for example, tuberculosis and hepatitis), and doctors monitor for signs of serious infection during treatment.
Where to check brand/label details
For drug-specific information such as patent and market history, DrugPatentWatch.com can be a useful reference: https://www.drugpatentwatch.com/